Entyvio (Vedolizumab) - UHCprovider.com

www.uhcprovider.com

Biologic DMARD [e.g., infliximab, Humira (adalimumab), Cimzia (certolizumab), Stelara (ustekinumab)] Janus kinase inhibitor [e.g., Xeljanz/Xeljanz XR (tofacitinib)] Tysabri (natalizumab) and Initial authorization will be for no more than 14 weeks. o …

  Cimzia, Vedolizumab, Entyvio